Aganepag (Synonyms: AGN 210937) manufacturers
- Aganepag
-
- $2270.00
-
2026-05-11
- CAS:910562-18-4
- Purity:
- Supply Ability: 10g
- Aganepag
-
- $2270.00
-
2025-10-28
- CAS:910562-18-4
- Purity:
- Supply Ability: 10g
|
| | Aganepag (Synonyms: AGN 210937) Basic information |
| Product Name: | Aganepag (Synonyms: AGN 210937) | | Synonyms: | Aganepag (Synonyms: AGN 210937);Aganepag (AGN 210937);Aganepag;AGN 210937;2-Thiophenecarboxylic acid, 5-[3-[(2S)-1-[4-[(1S)-1-hydroxyhexyl]phenyl]-5-oxo-2-pyrrolidinyl]propyl]- | | CAS: | 910562-18-4 | | MF: | C24H31NO4S | | MW: | 429.57 | | EINECS: | | | Product Categories: | | | Mol File: | 910562-18-4.mol |  |
| | Aganepag (Synonyms: AGN 210937) Chemical Properties |
| Boiling point | 678.6±55.0 °C(Predicted) | | density | 1.212±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 3.70±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Aganepag (Synonyms: AGN 210937) Usage And Synthesis |
| Uses | Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. | | IC 50 | EP2: 0.19 nM (EC50) | | References | [1] Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1 |
| | Aganepag (Synonyms: AGN 210937) Preparation Products And Raw materials |
|